Document is current
Any future updates will be listed below
-
Authors
Romagnolo, Alberto https://orcid.org/0000-0002-1312-1843
Fabbri, Margherita
Merola, Aristide
Montanaro, Elisa
Palermo, Sara
Martone, Tiziana
Seresini, Agostino
Goldwurm, Stefano
Rizzone, Mario Giorgio
Lopiano, Leonardo
- License Information
-
More Information
Article History
Received: 23 April 2018
Revised: 19 June 2018
Accepted: 20 June 2018
First Online: 26 June 2018
Compliance with ethical standards
:
: Dr. Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Lusofarmaco and UCB Pharma. Dr. Fabbri reports no disclosures. Dr. Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Abbvie, and Cynapsus Therapeutics. He has received grant support from Lundbeck. Dr. Montanaro reports no disclosures. Dr. Palermo reports no disclosures. Dr. Martone reports no disclosures. Dr. Seresini reports no disclosures. Dr. Goldwurm reports no disclosures. Dr. Rizzone has received honoraria for lecturing and travel grants from Medtronic and Zambon. Dr. Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma and AbbVie.
: The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The local institutional review board (Comitato Etico Interaziendale Città della Salute e della Scienza di Torino; CS/855; protocol number 475) approved the study and all participants provided written informed consent. The demented patients gave their informed assent, and a written informed consent was obtained from their legal representative.
: A. Romagnolo had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
